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Accurate lumpectomy cavity deﬁnition is critical in breast treatment planning. We compared contouring lumpectomy cavity
volume and cavity visualization score (CVS) with CT versus 3T MRI. 29 patients were imaged with CT and 3T MRI. Seven
additional boost planning sets were obtained for 36 image sets total. Three observers contoured the lumpectomy cavity on all
images, assigning a cavity visualization score (CVS ) of 1 to 5. Measures of consistency and agreement for CT volumes were
98.84% and 98.62%, for T1 MRI were 95.65% and 95.55%, and for T2 MRI were 97.63% and 97.71%. The mean CT, T1 MRI,
and T2 MRI CVS scores were 3.28, 3.38, and 4.32, respectively. There was a highly signiﬁcant diﬀerence between CT and T2 scores
(P<. 00001) and between T1 and T2 scores (P<. 00001). Interobserver consistency and agreement regarding volumes were high
for all three modalities with T2 MRI CVS the highest. MRI may contribute to target deﬁnition in selected patients.
1.Introduction
Deﬁnition of the lumpectomy cavity is a critical step in
treatment planning for irradiation of the intact breast, breast
boost, and for partial breast irradiation. Multiple studies
have shown the limitations of single modality imaging with
interobserver diﬀerences in lumpectomy cavity deﬁnition
[1–4]. CT-based imaging is commonly used for breast treat-
ment planning; but the limited soft tissue contrast of CT can
resultinpoorvisualizationofthelumpectomysiteinpatients
withdensebreastparenchyma,smalllumpectomycavities,or
a prolonged delay between surgery and treatment planning
[2, 3]. MR imaging provides superior soft tissue contrast
and may provide clearer visualization of the lumpectomy
cavity. Although the diagnostic role of MRI in breast cancer
management is expanding, MRI is rarely used as an imaging
modality in post-lumpectomy radiation therapy planning.
We compared contouring of the lumpectomy cavity volume
and cavity visualization score (CVS) based on CT imaging
compared to 3 Tesla magnetic resonance imaging, (3T MRI).
2.Methods andMaterials
This is an IRB-approved retrospective review of treatment
planning imaging obtained for breast cancer patients follow-
ing breast conserving surgery.
From September 2008 to July 2009, 29 patients referred
for intact breast irradiation had breast imaging performed
using both CT and noncontrast 3T MRI. Of these, seven
patients had repeat CT and MRI performed at the time of
boost planning, providing 36 image sets. Sixteen patients
did not receive chemotherapy. The average interval between
surgery and image acquisition for this group was 28 days
(range 14–52).
Eleven patients received postoperative adjuvant chem-
otherapy prior to radiation. The average interval between
surgery and image acquisition was 137 days (range 68–206)
for this group.
Twopatientshadneoadjuvantchemotherapyfollowedby
surgery, then radiation. The surgery-image intervals of these
2 patients were 38 and 57 days.2 International Journal of Breast Cancer
Table 1: Patient and imaging data.
Median Range
Age (years), N = 29 56.9 38–76
Interval from surgery to image
acquisition (days), N = 29
No chemotherapy N = 16 28 14–52
Adjuvant postoperative chemotherapy
N = 11 137 38–206
Neoadjuvant chemotherapy-before
surgery N = 2 47.5 38–57
Lumpectomy volume (cc) (Average of 3
contourers)
CT (n = 36
∗) 43.88 4.36–239.85
T1 MRI (n = 36) 40.94 4.51–285.97
T2 MRI (n = 28) 35.18 5.02–176.76
∗n = 29 patients with 7 boosts
All 36 image sets included a CT and T1 MRI. 28 image
sets also included a T2 MRI. CT scans were performed
with patients in the supine treatment position, both arms
extended above the head on a commercial arm board, with
wires deﬁning the breast and scars. A noncontrast MRI
was performed immediately afterward in the same position.
MRI scans were obtained with a 3T Scanner (Siemens TRIO
TIM) using a ﬂexible six-element body RF matrix coil.
The coil was placed over the patient’s chest in the supine
position. The 3D T1 weighted images were acquired using
VIBE (Volumetric interpolated breath-hold exam) sequence
with TR/TE: 3.37/1.23ms, 1 NEX at 2.4 × 2.0 × 2.0mm
spatial resolution in parallel imaging mode (acceleration
factor of 2) yielding 104 slices in 0.21 minutes. T2 weighted
images were obtained using a 2D Turbo spin echo sequence
with TR/TE: 6440/127ms, 3 NEX at 2.1 × 1.6 × 3.0mm
resolution with acceleration factor of 2 yielding 30–56 slices
in 6.02 minutes. Image distortions resulting from gradient
ﬁeld nonlinearity were corrected using a vendor supplied 3D
distortion algorithm, which compensates for slice curving
eﬀects in addition to in-plane distortions. The distortion
corrected images were imported into the treatment planning
system (TPS).
The MR images, as they do not contain the intrinsic
electron density information of tissues required for radiation
therapy planning, were registered/fused with CT images in
a two-step process. First, a coarse registration was achieved
usingamanualinteractiveregistrationtoolavailablewiththe
TPS (Pinnacle3 RTP, Phillips Medical Systems (Cleveland),
Inc., Fitchburg, WI, USA), which permits rigid-body trans-
formations (translations and rotations) on the secondary
image set (MRI) along and about the three major axes of the
primary (CT). Second, an automatic Local Correlation (LC)
registration algorithm (available with Syntegra registration
module of Pinnacle3 RTP) was applied to further enhance
the accuracy. The visualization tools-sliding window and/or
checkerboard were used to verify the clinical accuracy of the
fusion process.
Table 2: Cavity visualization score (CVS).
CVS Description
1 Cavity not visualized
2 Cavity visualized but margins indistinct
3 Cavity visualized with some distinct margins
4 Cavity with majority of margins distinct
5 All margins clearly seen
Three observers, a radiation oncologist, a dosimetrist,
and a radiation oncology resident independently contoured
the lumpectomy cavity on CT and MRI images (Table 1).
Surgical clips were occasionally, but not routinely, placed
in these patients by referring surgeons. When present, clips
were contoured independently as clips, not as part of the
lumpectomy cavity. Contourers outlined the visible seroma
cavity/tumor bed on CT. Associated stranding was not
contoured. For T1 and T2 MRI, the contourers outlined
the outermost contour of the boundary between tumor bed
and breast tissue. Measures of consistency and agreement
between observers for CT volume and MRI volume were
evaluated by the Intraclass Correlation Coeﬃcient (ICC)
obtained from a random eﬀect ANOVA model. All patients
had CT and T1 MRI scans; 28 had an additional T2 MRI
scan. Statistics are based on comparing CT images with T1
and T2 MRI images. The observers assigned each image a
cavity visualization score (CVS) of 1 (cavity not visualized)
to 5 (all cavity margins clearly deﬁned), see Table 2 (1).
3. Results
Measures of consistency and agreement for CT volumes were
98.84% and 98.62%. Measures for T1 MRI were 95.65%
for consistency and 95.55% for agreement. Measures for T2
MRIwere97.63%forconsistencyand97.71%foragreement.
There was a strong and signiﬁcant agreement between
observers. Observations do not diﬀer much in assessment
between CT and MRI. However, there was a signiﬁcant
diﬀerence in the perceived quality of the image measured
by cavity visualization score (CVS), see Figure 1.T h em e a n
CT, T1 MRI, and T2 MRI scores were 3.28, 3.38, and 4.32,
respectively. Analysis of variance (one-way ANOVA) was
usedtocompareallthreeCVSatonce.Therewasasigniﬁcant
diﬀerence between the scores (P value < .0001). Pairwise
comparisons showed no signiﬁcant diﬀerence between CT
scores and T1 scores (P = .43). There was a highly signiﬁcant
diﬀerence between CT and T2 scores (P<. 00001) and
between T1 and T2 scores (P<. 00001). Surgical clips,
when present, are easily seen on CT. They can sometimes be
visualized on T1 MRI by signal void, as seen in Figure 2.
4. Discussion
Breast conservation therapy with tumor directed surgery
followed by whole breast radiation has been an accepted
management of invasive breast cancer for several decades.International Journal of Breast Cancer 3
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Figure 1: Comparison of imaging modalities. (a) CT shows homogeneous gray area. Borders are distinct laterally. Medially, the borders
between lumpectomy cavity and breast parenchyma and chest wall are poorly deﬁned. CVS 3. (b) T1 MRI, noncontrast, shows cavity with
fairly well-deﬁned borders, some rim enhancement. CVS 4. (c) T2 MRI noncontrast shows hyperintense signal consistent with seroma,
distinct margins. CVS 5.
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Figure 2: (a) Biopsy clips visible on CT. (b) Biopsy clips seen as signal void on T1 MRI.
Recent trends in radiation oncology have focused on image-
based planning for the majority of disease sites including
breast cancer. The ﬁrst step in image-based treatment
planning of the intact breast following breast conserving
surgeryisaccurateidentiﬁcationandcontouringofthetarget
volume. Most series related to boost deﬁnition and partial
breast radiation therapy have deﬁned the post-lumpectomy
site as the volume on which subsequent planning is based.
Numerous studies have demonstrated that there is a great
deal of variability and uncertainty in this critical ﬁrst step.
The ability to identify the lumpectomy cavity varies from
patient to patient. Several factors, including breast density,
interval between surgery and image acquisition, and the
volume of the lumpectomy cavity, can present challenges
in distinguishing the lumpectomy site from the normal
breast with CT images. In a few instances, particularly
when several cycles of chemotherapy are delivered between
lumpectomy and initiation of radiation, the site of the
lumpectomy cavity cannot be identiﬁed. Even when visible,
postoperative stranding, borders between the lumpectomy
site and chest wall or skin, and dense breast parenchyma
can obscure the borders of the lumpectomy cavity. In addi-
tion to the challenges in identiﬁcation of the lumpectomy
site, several studies have shown interobserver diﬀerences
in contouring radiation target volumes [5–7]. Rates of
discordance in interobserver studies have conformity indices
approaching 50% [2, 8]. An RTOG multi-institutional and
multiobserver study showed clinically signiﬁcant diﬀerences
in target and organ at risk delineation for breast irradi-
ation, with some structure overlaps as low as 10% and
volume variations with standard deviations as high as 60%
[9].4 International Journal of Breast Cancer
MRI has improved soft tissue characterization compared
to CT and is used in breast cancer screening and presurgical
evaluation. As a screening modality, breast MRI has been
found to have a sensitivity of 93–100% [10, 11]. In a single
institutional retrospective study, presurgery breast MRI
changedbreastcancersurgicalmanagementin9.7%ofnewly
diagnosed cases [12]. Although MRI has a high resolution
and sensitivity in breast tissue, it has not been widely used in
radiation therapy treatment planning. Reasons may include
lack of access, cost, and lack of data on the utility of MRI
imaging for this purpose. In addition, there are issues related
to patient position, soft tissue deformation, and spatial
accuracy. Ahn et al. designed an MRI imaging protocol for
treatment planning with the patient in a prone position
anddemonstratedadequatecontrastandspatialﬁdelity[13].
Whipp and Halliwell obtained postoperative MRIs in 100
randomly selected breast cancer patients [14]. The images
were obtained in a single open MRI scanner using the con-
ventional breast radiotherapy treatment position, without
contrast, prior to routine two-dimensional simulation. MRI
results were qualitatively diﬀerent from CT and ultrasound
cavities described in the literature. 85% of the MRI volumes
were described as heterogeneous, 9% were described as
homogeneous. 88% were described as complex/cystic and
5% as simple cystic. Regular concentric rings of diﬀering
signal were seen within the postoperative complex in 32%
of scans. The postoperative complex was in contact with
the chest wall in 53% of patients. A follow-up study by this
group reported on local recurrence rates after MRI-assisted
radiotherapy planning [15]. The lumpectomy site, described
as the postoperative complex (POCx) was visible on MRI
of all 221 patients. MRI imaging was used in the context
of conventional treatment planning and altered the standard
ﬁeld margins in 69% of patients.
The University of Iowa Hospital and Clinics Department
of Radiation Oncology has a 3T MRI device present in
the department for treatment planning. Although diagnostic
breast MRI is usually obtained in a prone position, we
preferred to continue our treatment planning and treatment
delivery in the supine position. Many of our patients have
a BMI greater than 30 and would be uncomfortable in a
prolonged prone position. Image acquisition at 3T using
surface coils combined with the parallel imaging approach
resulted in an improved SNR and adequate coverage. Since
the MRI was obtained for treatment planning and not for
diagnosis, we did not use contrast. We used a surface coil
and found minimal deformation of breast tissue. Obtaining
the noncontrast T1 and T2 images adds an additional 16
minutes to the treatment planning time. As described above,
the MRI images provided a greater detail than the CT
images, showing heterogeneous cavities and concentric rings
of granulation tissue. The lumpectomy cavity is identiﬁed by
a bright signal on the T2 image and shows clear demarcation
between seroma and normal tissue. In this study, the T2
images provided the best cavity visualization score, which
was signiﬁcantly better than that of the CT or T1 MRI. MRI,
particularlyT2MRI,betterdemarcatedtheinterfacebetween
seroma and chest wall, seroma and skin, and distinguished
between seroma and dense breast parenchyma (Figure 1).
5. Conclusion
MRI provides more detailed visual information than CT
in the post-lumpectomy breast. In patients with diﬃcult
to visualize cavities, the addition of MRI images to CT
treatment planning may contribute to improved target
volume deﬁnition. In our experience, a noncontrast MRI
image can be obtained in the supine treatment planning
position in a reasonable period of time during the treatment
planning session.
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